title: Effect of the period of treatment with a single dose of propylthiouracil on the antibody response in rats.
abstract: Propylthiouracil (PTU) was employed in a fixed quantity to evaluate the effect of the period of treatment with this drug on the antibody response to sheep red blood cells in Wistar rats. Animals were treated for 8, 16, 30 and 90 days by intragastric route with 5 mg/day, and immunized 24 h following the end of treatment; other groups were treated for 21 days, and immunized on the 17th day of treatment. Animals were sacrificed 5 or 6 days following immunization; the primary response was evaluated by the number of plaque-forming spleen cells and in some cases also by enzyme-linked immunosorbent assay (ELISA). Secondary response of PTU-treated rats, immunized and boostered after 15 days, was evaluated by ELISA 3 days following the booster. RIA performed the measurement of T3 in animals treated for 16 days, immunized, and sacrificed after 1, 2, 3, 4 and 5 days following immunization. Results showed that treatment for 8 and 16 days increased production of antibodies, and for 30 and 90 days decreased this response. Thus, according to the period of treatment, the same dose of PTU stimulates or suppresses the antibody response. This biphasic effect of a single dose of PTU was independent of alterations of serum levels of T3 during the buildup of the immune response. These results contributes towards the understanding of the literature controversy regarding the effects of this drug on the immune response, and could be of interest for studies involving autoimmune processes in thyroid.
authors.affiliation: Depto. Física e Química, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Ribeirão Preto, SP 14040903, Brazil.
authors.forename: C G
authors.initials: CG
authors.lastname: Duarte
authors.forename: A E C S
authors.initials: AE
authors.lastname: Azzolini
authors.forename: A I
authors.initials: AI
authors.lastname: Assis-Pandochi
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D006462:Hemolytic Plaque Technique; D007114:Immunization; D008297:Male; D011441:Propylthiouracil / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000276:immunology; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
chemical_list: D013956:Antithyroid Agents; D014284:Triiodothyronine; D011441:Propylthiouracil